Skip to main content
Premium Trial:

Request an Annual Quote

Harvard Bio to Cut Staff at Genomic Solutions UK Operations

NEW YORK, June 7 (GenomeWeb News) - Harvard Bioscience plans to eliminate certain jobs at the Huntingdon, UKfacility of its Genomic Solutions subsidiary, according to an 8-K filed with the US Securities and Exchange Commission.


In the filing, Harvard Bioscience said that it will reorganize, consolidate, and eliminate certain activities at the facility. Part of the reorganization includes relocating some activities to the firm's Holliston, Mass., facilities.


According to Harvard Bio, "this will result in the elimination of a number of employee positions."


The firm expects to take second-quarter charges of $600,000 to $800,000 related to severance and benefits and charges of $100,000 to $300,000 related to lease terminations.


Genomic Solutions is part of Harvard Bio's capital equipment business, which the firm last August said it plans to divest. At that time, Harvard Bio said it expected to complete the divestiture or sale within one year.


According to the most recent filing, Harvard Bio is continuing its efforts to divest the capital equipment business. The firm said it would kill the reorganization plan if it sells the business "prior to our completion of all activities under this plan."

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.